Apellis Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript
Good afternoon and welcome to Cowen and Company's 42nd Annual Health Care Conference, hopefully its last virtual edition. I'm Phil Nadeau, one of the biotech analysts here at Cowen. It's my pleasure to moderate a fireside chat with Apellis Pharmaceuticals today. We have Tim Sullivan and Cedric Francois sharing a screen. We're really happy to have you guys with us today. And Adam Townsend, Chief Commercial Officer, is also here, apparently in a different room.
Thanks so much for joining us, guys. Really appreciate it. We know these are exciting times for Apellis with one launch going in now and an FDA filing coming up shortly.
Questions & Answers
So, Cedric, maybe I'll hand it to you. Can you give us a brief state of the company overview, biggest strengths, biggest challenges, what needs to happen to drive outperformance over the next year or two?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
